TELA Bio, Inc. (TELA) Misses Q1 EPS by 5c

TELA Bio, Inc. (NASDAQ: TELA) reported Q1 EPS of ($0.25), $0.05 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $18.5 million versus the consensus estimate of $21.05 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.

You May Also Be Interested In

• Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
• Deere conference call: 2027 orders up mid-single digits from last year)
• Deere shares climb as fiscal Q3 earnings and revenue top estimates